AGN 193109-d7 |
| Catalog No.GC46817 |
An internal standard for the quantification of AGN 193109
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1216429-25-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
AGN 193109-d7 is intended for use as an internal standard for the quantification of AGN 193109 by GC- or LC-MS. AGN 193109 is an antagonist of retinoic acid receptors (RARs).1 AGN 193109 decreases expression of cytokeratin K5-8, 13, 14, 16, 17, and 19 genes, markers of retinoid action in ECE16-1 cells, when co-administered with TTNPB but not when used alone. In vivo, AGN 193109 induces cleft palate or frontonasal dysplasia and eye malformations in fetuses of pregnant mice following a single oral dose of 1 mg/kg.2
1.Agarwal, C., Chandraratna, A.S., Johnson, A.L., et al.AGN193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cellsJ. Biol. Chem.271(21)12209-12212(1996) 2.Kochhar, D.M., Jiang, H., Penner, J.D., et al.The use of a retinoid receptor antagonist in a new model to study vitamin A-dependent developmental eventsInt. J. Dev. Biol.42(4)601-608(1998)
Average Rating: 5 (Based on Reviews and 35 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *